AMEX · Financial Statements

Milestone Scientific, Inc. (MLSS) Revenue, Earnings & Financial Statements

$0.28 AMEX: MLSS Market Cap $25.10M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Milestone Scientific, Inc. most recently reported annual revenue of $9.0M, a net loss of $6.0M. Revenue grew at an average annual rate of 12.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Milestone Scientific, Inc.: Revenue fell from $10.0M in 2016 to $9.0M in 2025, a change of -10.0% over 9 years; net profit was positive in 0 of 10 reported years; operating margin moved from -62.1% to -63.5%, a shift of -1.3 percentage points; the most recent year shows a net loss of $6.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$10.0M$11.0M$10.0M$8.0M$5.0M$10.0M$9.0M$10.0M$9.0M$9.0M
Operating Expenses$17.0M$17.0M$18.0M$12.0M$13.0M$18.0M$18.0M$17.0M$15.0M$15.0M
Operating Profit−$7.0M−$5.0M−$8.0M−$4.0M−$7.0M−$7.0M−$9.0M−$7.0M−$7.0M−$6.0M
Operating Margin-62.1%-46.4%-83.1%-47.8%-137.1%-71.6%-100.2%-72.3%-78.3%-63.5%
Other Income$0$0$0−$4.0M$0$1.0M$0$0$2.0M$0
Interest$0$0$0$0$0$0$0$0$0$0
Depreciation$0$1.0M$1.0M$0$0$0$0$0$0$0
Profit Before Tax−$7.0M−$5.0M−$8.0M−$8.0M−$7.0M−$7.0M−$9.0M−$7.0M−$5.0M−$6.0M
Tax rate (%)0.3%-0.4%-0.3%-0.2%-0.2%0.0%0.0%0.0%0.0%0.0%
Net Profit−$6.0M−$5.0M−$7.0M−$8.0M−$7.0M−$7.0M−$9.0M−$7.0M−$5.0M−$6.0M
EPS−$0.22−$0.16−$0.21−$0.17−$0.12−$0.10−$0.12−$0.10−$0.06−$0.07

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$2.0M$2.0M$2.0M$3.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$3.0M$2.0M
Operating Expenses$4.0M$4.0M$4.0M$4.0M$4.0M$4.0M$4.0M$3.0M$3.0M$3.0M$4.0M$3.0M
Operating Profit−$2.0M−$1.0M−$2.0M−$1.0M−$2.0M−$2.0M−$1.0M−$1.0M−$1.0M−$1.0M−$1.0M−$1.0M
Operating Margin-87.6%-65.2%-96.0%-58.4%-101.4%-89.5%-63.9%-48.1%-52.5%-38.3%-37.4%-33.6%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax−$2.0M−$1.0M$0−$1.0M−$2.0M−$2.0M−$1.0M−$1.0M−$1.0M−$1.0M−$1.0M−$1.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$2.0M−$1.0M$0−$1.0M−$2.0M−$2.0M−$1.0M−$1.0M−$1.0M−$1.0M−$1.0M−$1.0M
EPS−$0.03−$0.02$0.00−$0.02−$0.03−$0.02−$0.02−$0.01−$0.01−$0.01−$0.01−$0.01

Over the 10 years reported for Milestone Scientific, Inc., cash stood at $1.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.75 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$14.0M$16.0M$6.0M$7.0M$20.0M$20.0M$14.0M$11.0M$10.0M$8.0M
Current Assets$13.0M$12.0M$6.0M$6.0M$19.0M$19.0M$13.0M$11.0M$9.0M$7.0M
Cash$4.0M$3.0M$1.0M$2.0M$14.0M$15.0M$9.0M$3.0M$3.0M$1.0M
Inventory$5.0M$3.0M$2.0M$2.0M$2.0M$2.0M$2.0M$3.0M$4.0M$4.0M
Receivables$4.0M$3.0M$2.0M$2.0M$1.0M$1.0M$1.0M$0$0$1.0M
Fixed Assets$0$0$0$0$1.0M$1.0M$0$0$0$0
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$1.0M$0$0$0$0$0$3.0M$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0
Total Liabilities$5.0M$8.0M$5.0M$5.0M$3.0M$4.0M$4.0M$3.0M$4.0M$5.0M
Current Liabilities$5.0M$7.0M$5.0M$5.0M$3.0M$3.0M$3.0M$3.0M$4.0M$4.0M
Borrowings$0$0$0$0$1.0M$1.0M$0$0$0$1.0M
Other Liabilities$5.0M$8.0M$5.0M$5.0M$3.0M$3.0M$3.0M$3.0M$4.0M$4.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$9.0M$7.0M$2.0M$2.0M$16.0M$16.0M$10.0M$8.0M$6.0M$3.0M

For Milestone Scientific, Inc., operating cash flow was positive in 0 of 10 reported years; free cash flow in the latest year was negative at $3.0M; free cash flow was positive in 0 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow−$5.0M−$1.0M−$2.0M−$2.0M−$7.0M−$4.0M−$6.0M−$5.0M−$3.0M−$3.0M
Investing Cash Flow$0−$1.0M$0$0$0$0$0−$3.0M$3.0M$0
Financing Cash Flow$0$0$0$0$0$0$0$0$0$0
Net Cash Flow−$1.0M−$1.0M−$2.0M$1.0M$13.0M$1.0M−$6.0M−$6.0M$0−$2.0M
Free Cash Flow−$5.0M−$1.0M−$2.0M−$2.0M−$7.0M−$4.0M−$6.0M−$5.0M−$3.0M−$3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.09
EV / EBITDA-7.50
FCF Yield-5.27%
Quick Ratio1.23
Interest Coverage-155.32
Return 1Y-18.42%
Return 3Y-62.65%
Return 5Y-87.24%

Milestone Scientific, Inc. (MLSS) financials — frequently asked questions

What is Milestone Scientific, Inc.'s annual revenue?

Milestone Scientific, Inc. (MLSS) reported annual revenue of $9.0M in its most recent fiscal year.

What is Milestone Scientific, Inc.'s net profit?

Milestone Scientific, Inc. (MLSS) reported a net loss of $6.0M in its most recent fiscal year.

What is MLSS EV/EBITDA?

Milestone Scientific, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -7.50. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Medical - Instruments & Supplies stocks

BDX revenue $19.5BMDLN stockWST revenue $3.1BSOLV revenue $8.3BBAX revenue $11.2BCOO revenue $4.1BRGEN revenue $738.0MAVTR revenue $6.6BATR revenue $3.8BBLCO revenue $5.1BAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
MLSS Overview MLSS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.